Insights

Innovative R&D Focus Orion Pharma's core R&D areas are oncology and pain, with proprietary treatments targeting cancer and neurological diseases. This focus presents opportunities to collaborate or offer specialized solutions that support their pharmaceutical development pipeline.

Global Expansion & Partnerships Recent collaborations with companies like Evariste, Quantori, and Newel Health indicate Orion's commitment to expanding its research, digital therapeutics, and pharmaceutical offerings. Engaging with their strategic partners could unlock additional market entry points.

Financial Stability With net sales of approximately EUR 1,542 million and a workforce of around 3,700 globally, Orion Pharma demonstrates strong financial health, making them a reliable partner for joint ventures, technology integrations, or supply chain solutions.

Advanced Tech Stack Utilizing cloud platforms like Oracle Cloud, AI tools such as PyTorch, and analytics via Google Analytics showcases Orion's embrace of cutting-edge technology, opening doors for innovative tech solutions, data analytics, and AI-driven services.

Market Position & Opportunities As a prominent Nordic pharmaceutical company listed on Nasdaq Helsinki with a diverse product portfolio, Orion Pharma offers potential sales avenues in pharmaceuticals, healthcare consumer products, and digital health initiatives aligned with their strategic growth.

Orion Pharma Tech Stack

Orion Pharma uses 8 technology products and services including Oracle Cloud, Emotion, jQuery, and more. Explore Orion Pharma's tech stack below.

  • Oracle Cloud
    Data Management Platforms
  • Emotion
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • PyTorch
    Machine Learning
  • Linux
    Programming Languages
  • YouTube
    Video Players
  • Google Analytics
    Web Analytics

Media & News

Orion Pharma's Email Address Formats

Orion Pharma uses at least 1 format(s):
Orion Pharma Email FormatsExamplePercentage
First.Last@orion.fiJohn.Doe@orion.fi
97%
Last.First@orion.fiDoe.John@orion.fi
2%
FirstL@orion.fiJohnD@orion.fi
1%

Frequently Asked Questions

What is Orion Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Orion Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orion Pharma's stock symbol?

Minus sign iconPlus sign icon
Orion Pharma is a publicly traded company; the company's stock symbol is ONL.

What is Orion Pharma's official website and social media links?

Minus sign iconPlus sign icon
Orion Pharma's official website is orion.fi and has social profiles on LinkedIn.

How much revenue does Orion Pharma generate?

Minus sign iconPlus sign icon
As of December 2025, Orion Pharma's annual revenue is estimated to be $5B.

What is Orion Pharma's NAICS code?

Minus sign iconPlus sign icon
Orion Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Orion Pharma have currently?

Minus sign iconPlus sign icon
As of December 2025, Orion Pharma has approximately 3.1K employees across 6 continents, including EuropeAsiaNorth America. Key team members include Cio: S. M.Chief Commercial Officer & Us Country Head, Innovative Medicines: G. J.Chief Medical Officer, Head Of Global Medical Affairs: P. R.. Explore Orion Pharma's employee directory with LeadIQ.

What industry does Orion Pharma belong to?

Minus sign iconPlus sign icon
Orion Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Orion Pharma use?

Minus sign iconPlus sign icon
Orion Pharma's tech stack includes Oracle CloudEmotionjQuerySwiperPyTorchLinuxYouTubeGoogle Analytics.

What is Orion Pharma's email format?

Minus sign iconPlus sign icon
Orion Pharma's email format typically follows the pattern of First.Last@orion.fi. Find more Orion Pharma email formats with LeadIQ.

Orion Pharma

Pharmaceutical ManufacturingUusimaa, Finland1001-5000 Employees

Orion Corporation is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. 

We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion Corporation has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Corporation are used to treat cancer, neurological diseases and respiratory diseases, among others. 

In 2024 Orion Group's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion Group's A and B shares are listed on Nasdaq Helsinki.

Product related questions and feedback: https://www.orionpharma.com/feedback

Beware of any recruitment scam using Orion Pharma’s name

Be cautious of recruitment scams where individuals pose as Orion Pharma employees or authorized recruiters. Orion Pharma will never request payment, personal financial information, or any favours at any stage of our hiring process.

Section iconCompany Overview

Phone number
Website
orion.fi
Stock Symbol
ONL
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Orion Pharma's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Orion Pharma's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.